MX9600022A - Excipiente de liberacion sostenida. - Google Patents

Excipiente de liberacion sostenida.

Info

Publication number
MX9600022A
MX9600022A MX9600022A MX9600022A MX9600022A MX 9600022 A MX9600022 A MX 9600022A MX 9600022 A MX9600022 A MX 9600022A MX 9600022 A MX9600022 A MX 9600022A MX 9600022 A MX9600022 A MX 9600022A
Authority
MX
Mexico
Prior art keywords
release excipient
sustained release
cross
heteropolysaccharide
linking
Prior art date
Application number
MX9600022A
Other languages
English (en)
Inventor
Anand R Baichwal
Troy W Mccall
Original Assignee
Mendell Co Inc Edward
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mendell Co Inc Edward filed Critical Mendell Co Inc Edward
Publication of MX9600022A publication Critical patent/MX9600022A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Character Spaces And Line Spaces In Printers (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Superstructure Of Vehicle (AREA)
  • Memory System Of A Hierarchy Structure (AREA)
  • Push-Button Switches (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Un excipiente de liberacion sostenida para utilizar en formas de dosificacion solido oral incluye de aproximadamente 15 a aproximadamente 30 por ciento o más en peso de goma heteropolisacárida; una cantidad efectiva de un agente de entrelazamiento cationico capaz de entrelazar el heteropolisacárido en un ambiente de uso y un relleno farmacéutico inerte.
MX9600022A 1994-04-25 1996-01-03 Excipiente de liberacion sostenida. MX9600022A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23262594A 1994-04-25 1994-04-25

Publications (1)

Publication Number Publication Date
MX9600022A true MX9600022A (es) 1998-06-30

Family

ID=22873888

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9600022A MX9600022A (es) 1994-04-25 1996-01-03 Excipiente de liberacion sostenida.

Country Status (18)

Country Link
EP (2) EP0706377B1 (es)
JP (1) JP3279318B2 (es)
KR (1) KR100232020B1 (es)
CN (1) CN1131023C (es)
AT (2) ATE308318T1 (es)
AU (1) AU705378B2 (es)
CA (1) CA2164513C (es)
DE (2) DE69524358T2 (es)
DK (1) DK0706377T3 (es)
ES (2) ES2246961T3 (es)
FI (1) FI119353B (es)
HK (1) HK1040487B (es)
HU (1) HU219818B (es)
IL (1) IL113167A (es)
MX (1) MX9600022A (es)
PT (1) PT706377E (es)
TW (1) TW357085B (es)
WO (1) WO1995028916A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6590598A (en) * 1997-04-04 1998-10-30 Monsanto Company Hydrolysable delivery system using cross-linked polymeric resins as vehicles
US6890524B1 (en) 1997-04-04 2005-05-10 Monsanto Company Hydrolyzable delivery system using cross-linked polymeric resins as vehicles
US6471955B1 (en) 1997-04-04 2002-10-29 Pharmacia Corporation Ph-selective delivery system using crosslinked polymeric resins as vehicles
CN1268338C (zh) 2001-07-06 2006-08-09 恩德制药公司 用作止痛剂的6－羟基羟吗啡酮的口服给药
US20030091635A1 (en) * 2001-09-26 2003-05-15 Baichwal Anand R. Opioid formulations having reduced potential for abuse
CA2481091A1 (en) * 2002-04-05 2003-10-23 Penwest Pharmaceuticals Co. Sustained release metoprolol formulations
KR101999055B1 (ko) * 2018-02-28 2019-10-01 경북대학교 산학협력단 과황산 이온 서방성 구조체, 이의 제조방법 및 이를 이용한 유기 오염 물질 처리 방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303691A (en) * 1977-11-09 1981-12-01 Anderson, Clayton & Co. Proteinaceous food product
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4764380A (en) * 1982-03-22 1988-08-16 Alza Corporation Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
HU209251B (en) * 1992-03-13 1994-04-28 Synepos Ag Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5399358A (en) * 1993-11-12 1995-03-21 Edward Mendell Co., Inc. Sustained release formulations for 24 hour release of metroprolol
US5399362A (en) * 1994-04-25 1995-03-21 Edward Mendell Co., Inc. Once-a-day metoprolol oral dosage form

Also Published As

Publication number Publication date
TW357085B (en) 1999-05-01
IL113167A (en) 2001-01-28
DK0706377T3 (da) 2002-04-02
JP3279318B2 (ja) 2002-04-30
HU9503456D0 (en) 1996-02-28
HK1040487A1 (en) 2002-06-14
EP1145712A1 (en) 2001-10-17
DE69524358T2 (de) 2002-06-13
FI956209A0 (fi) 1995-12-22
ES2164764T3 (es) 2002-03-01
JPH08512061A (ja) 1996-12-17
FI956209A (fi) 1995-12-22
FI119353B (fi) 2008-10-31
HUT73636A (en) 1996-08-28
ES2246961T3 (es) 2006-03-01
ATE209906T1 (de) 2001-12-15
CA2164513A1 (en) 1995-11-02
KR100232020B1 (ko) 1999-12-01
EP0706377B1 (en) 2001-12-05
WO1995028916A1 (en) 1995-11-02
EP1145712B1 (en) 2005-11-02
ATE308318T1 (de) 2005-11-15
HK1040487B (zh) 2006-05-12
DE69534575D1 (de) 2005-12-08
EP0706377A1 (en) 1996-04-17
PT706377E (pt) 2002-05-31
KR960703016A (ko) 1996-06-19
IL113167A0 (en) 1995-06-29
HU219818B (hu) 2001-08-28
CN1131023C (zh) 2003-12-17
CN1127469A (zh) 1996-07-24
CA2164513C (en) 1999-09-21
DE69534575T2 (de) 2006-07-13
AU2198295A (en) 1995-11-16
AU705378B2 (en) 1999-05-20
EP0706377A4 (en) 1996-11-06
DE69524358D1 (de) 2002-01-17

Similar Documents

Publication Publication Date Title
HUT75881A (en) Pharmaceutical composition for 24 hour release of metoprolol
IL112637A0 (en) A pharmaceutical composition containing oxybutynin and methods for the preparation thereof
DE3373272D1 (en) Sustained release diethylpropion compositions
NO20053106L (no) Oral, analgesisk doseringsform med forlenget frigivelse.
KR100257803B1 (en) Stable hydrated cephalosporin dry powder for oral suspension formulation
MX9600022A (es) Excipiente de liberacion sostenida.
CS240991A3 (en) Solid forms for oral administration, said forms containing iphosphamide as active component
HK1004549A1 (en) Carbostyril derivatives and pharmaceutical compositions containing the same for use as a disturbance-of-consciousness improving agent central nervous system stimulant or sigma receptor agonist
IL109866A (en) Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine(+)L-hydrogentartrate its preparation and pharmaceutical compositions containing it

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status

Owner name: BELLSOUTH INTELLECTUAL PROPERTY CORPORATION.*

MM Annulment or lapse due to non-payment of fees